A new trading day began on Tuesday, with Geron Corp (NASDAQ: GERN) stock price down -2.19% from the previous day of trading, before settling in for the closing price of $1.37. GERN’s price has ranged from $1.04 to $3.68 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 5.60% over the past five years. Meanwhile, its annual earnings per share averaged 61.11%. With a float of $607.30 million, this company’s outstanding shares have now reached $638.36 million.
Geron Corp (GERN) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 4.87%, while institutional ownership is 75.55%. The most recent insider transaction that took place on Dec 15 ’25, was worth 27,400. Before that another transaction happened on May 09 ’25, when Company’s Director bought 13,300 for $1.18, making the entire transaction worth $15,667. This insider now owns 13,300 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 61.11% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Here are Geron Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.66.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.12, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.04 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Geron Corp (NASDAQ: GERN) saw its 5-day average volume 4.08 million, a negative change from its year-to-date volume of 10.71 million. As of the previous 9 days, the stock’s Stochastic %D was 40.00%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 58.82%, which indicates a significant increase from 54.17% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0757 in the past 14 days, which was higher than the 0.0692 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2394, while its 200-day Moving Average is $1.3543. Nevertheless, the first resistance level for the watch stands at $1.3700 in the near term. At $1.4000, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4200. If the price goes on to break the first support level at $1.3200, it is likely to go to the next support level at $1.3000. Assuming the price breaks the second support level, the third support level stands at $1.2700.
Geron Corp (NASDAQ: GERN) Key Stats
With a market capitalization of 855.40 million, the company has a total of 638,355K Shares Outstanding. Currently, annual sales are 76,990 K while annual income is -174,570 K. The company’s previous quarter sales were 47,230 K while its latest quarter income was -18,430 K.
